SANGUINE CORP. (SGNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ColleenB who wrote (3023)	7/12/1998 1:50:00 PM
From: Prospector	Read Replies (2) of 5402

Cardioplegia ::: The first application for the Company's product is priming the heart-lung machine (in open heart surgery). There are appoximately 300,000 cases per year in the U.S. that require oxygenation of a heart-lung machine's priming solution. This appliction is non-controversial and is desired by all cardiac surgeons. Today there is not an adequate oxygen carrying product available in the marketplace. Prospector

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next